Home
Sites

Select country

Depression & Schizophrenia

Treating comorbidity of depression and anxiety and addressing side effects of some medications

At ENCP 2021, Professor Roger McIntyre chatted with us about anxiety in people with major depressive disorder (MDD) and how it can impact both MDD symptoms and recovery. Treating anxiety can help alleviate MDD and lead to better overall health outcomes. Also discussed was how people with schizophrenia or MDD may be fully open to taking a treatment; however, if they then experience sedating or activating side effects, it can be frustrating for both the patients and physicians and can lead to treatment discontinuation and then potential symptom worsening.

 

ECNP : European College of Neuropsychopharmacology 

MDD: Major depressive disorder

 

BE-NOTPR-0143, approval date 03/2022

Related

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
Not located in Brazil?
Go to a different regional HUB
Continue to Progress in MindContinue to Progress in Mind BrazilContinue to Progress in Mind MENAContinue to Progress in Mind SpainContinue to Progress in Mind ItalyContinue to Progress in Mind GreeceContinue to Progress in Mind South East AsiaContinue to Progress in Mind Middle East & AfricaContinue to Progress in Mind United KingdomContinue to Progress in Mind SwedenContinue to Progress in Mind NorgeContinue to Progress in Mind DenmarkContinue to Progress in Mind Japan RCContinue to Progress in Mind БългарияContinue to Progress in Mind IsraelContinue to Progress in Mind SwedenContinue to Progress in Mind FinlandContinue to Progress in Mind UkraineContinue to Progress in Mind Belgium & LuxembourgContinue to Progress in Mind SwitzerlandContinue to Progress in Mind GermanyContinue to Progress in Mind Austria
You are leaving Progress in Mind
Continue to
Cancel
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intended for health care professionals.
All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Accept
Decline
Congress
Register for access to Progress in Mind in your country
Cancel
New member registration